Melanoma Cell Resistance to Vemurafenib Modifies Inter-Cellular Communication Signals
Melanoma Cell Resistance to Vemurafenib Modifies Inter-Cellular Communication Signals
About this item
Full title
Author / Creator
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
The therapeutic success of BRAF inhibitors (BRAFi) and MEK inhibitors (MEKi) in BRAF-mutant melanoma is limited by the emergence of drug resistance, and several lines of evidence suggest that changes in the tumor microenvironment can play a pivotal role in acquired resistance. The present study focused on secretome profiling of melanoma cells sensi...
Alternative Titles
Full title
Melanoma Cell Resistance to Vemurafenib Modifies Inter-Cellular Communication Signals
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_4f522836841d4fdd87db2194d3c3be0f
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4f522836841d4fdd87db2194d3c3be0f
Other Identifiers
ISSN
2227-9059
E-ISSN
2227-9059
DOI
10.3390/biomedicines9010079
